188 related articles for article (PubMed ID: 29306942)
21. Sialylation pattern in lung epithelial cell line and Siglecs expression in monocytic THP-1 cells as cellular indicators of cigarette smoke - induced pathology in vitro.
Wielgat P; Trofimiuk E; Czarnomysy R; Holownia A; Braszko JJ
Exp Lung Res; 2018 Apr; 44(3):167-177. PubMed ID: 29781747
[TBL] [Abstract][Full Text] [Related]
22. Specific regulator of eosinophil apoptosis: Siglec-8-new hope for bronchial asthma treatment.
Feng YH; Mao H
Chin Med J (Engl); 2012 Jun; 125(11):2048-52. PubMed ID: 22884075
[TBL] [Abstract][Full Text] [Related]
23. Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.
Ibarlucea-Benitez I; Weitzenfeld P; Smith P; Ravetch JV
Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34155121
[TBL] [Abstract][Full Text] [Related]
24. Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients.
Wielgat P; Mroz RM; Stasiak-Barmuta A; Szepiel P; Chyczewska E; Braszko JJ; Holownia A
Adv Exp Med Biol; 2015; 839():1-5. PubMed ID: 25252903
[TBL] [Abstract][Full Text] [Related]
25. Erythrocyte sialoglycoproteins engage Siglec-9 on neutrophils to suppress activation.
Lizcano A; Secundino I; Döhrmann S; Corriden R; Rohena C; Diaz S; Ghosh P; Deng L; Nizet V; Varki A
Blood; 2017 Jun; 129(23):3100-3110. PubMed ID: 28416510
[TBL] [Abstract][Full Text] [Related]
26. "Siglec"ting the allergic response for therapeutic targeting.
Bochner BS
Glycobiology; 2016 Jun; 26(6):546-52. PubMed ID: 26911285
[TBL] [Abstract][Full Text] [Related]
27. Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease.
Kiser ZM; Lizcano A; Nguyen J; Becker GL; Belcher JD; Varki AP; Vercellotti GM
Blood Cells Mol Dis; 2020 Mar; 81():102399. PubMed ID: 31901888
[TBL] [Abstract][Full Text] [Related]
28. SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity.
Bouti P; Blans C; Klein BJAM; Shome D; Nadafi R; Van Houdt M; Schornagel K; Verkuijlen PJJH; Roos V; Reijmers RM; Van Bruggen R; Kuijpers TW; Matlung HL
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38138970
[TBL] [Abstract][Full Text] [Related]
29. Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer.
Daly J; Carlsten M; O'Dwyer M
Front Immunol; 2019; 10():1047. PubMed ID: 31143186
[TBL] [Abstract][Full Text] [Related]
30. Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA; Leung J; Falahati R; Williams J; Schanin J; Brock EC; Singh B; Chang AT; O'Sullivan JA; Schleimer RP; Tomasevic N; Bebbington CR; Bochner BS
Cells; 2020 Dec; 10(1):. PubMed ID: 33374255
[TBL] [Abstract][Full Text] [Related]
31. Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.
Elovaara H; Parkash V; Fair-Mäkelä R; Salo-Ahen OM; Guédez G; Bligt-Lindén E; Grönholm J; Jalkanen S; Salminen TA
PLoS One; 2016; 11(11):e0166935. PubMed ID: 27893774
[TBL] [Abstract][Full Text] [Related]
32. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
Linnartz-Gerlach B; Mathews M; Neumann H
Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
[TBL] [Abstract][Full Text] [Related]
33. Splenic CD163
Yuste M; Fernández-Caballero T; Prieto C; Álvarez B; Martínez-Lobo J; Simarro I; Castro JM; Alonso F; Ezquerra Á; Domínguez J; Revilla C
Vet Microbiol; 2017 Jan; 198():72-80. PubMed ID: 28062010
[TBL] [Abstract][Full Text] [Related]
34. Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environment.
von Gunten S; Yousefi S; Seitz M; Jakob SM; Schaffner T; Seger R; Takala J; Villiger PM; Simon HU
Blood; 2005 Aug; 106(4):1423-31. PubMed ID: 15827126
[TBL] [Abstract][Full Text] [Related]
35. Siglec-7 expression is reduced on a natural killer (NK) cell subset of obese humans.
Rosenstock P; Horstkorte R; Gnanapragassam VS; Harth J; Kielstein H
Immunol Res; 2017 Oct; 65(5):1017-1024. PubMed ID: 28786023
[TBL] [Abstract][Full Text] [Related]
36. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
[TBL] [Abstract][Full Text] [Related]
37. mSiglec-E, a novel mouse CD33-related siglec (sialic acid-binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain-containing protein tyrosine phosphatases SHP-1 and SHP-2.
Yu Z; Maoui M; Wu L; Banville D; Shen S
Biochem J; 2001 Feb; 353(Pt 3):483-92. PubMed ID: 11171044
[TBL] [Abstract][Full Text] [Related]
38. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
39. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
[TBL] [Abstract][Full Text] [Related]
40. Ganglioside binding pattern of CD33-related siglecs.
Rapoport E; Mikhalyov I; Zhang J; Crocker P; Bovin N
Bioorg Med Chem Lett; 2003 Feb; 13(4):675-8. PubMed ID: 12639556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
